P. Brian Hardy

University of North Carolina at Chapel Hill

Papers

1

Total Citations

11

H-Index

1

About

Dr. P. Brian Hardy is a pioneering chemical biologist whose work centers on the development of innovative computational tools for fragment-based drug discovery, with a particular focus on targeting challenging, "hard-to-drug" proteins. His most notable contribution is the creation of FRASE-bot (FRASE-based hit-finding robot), an in silico platform that accelerates the identification of chemical probes for undrugged targets. In a landmark 2024 study, Hardy and his team demonstrated FRASE-bot's power by successfully designing novel anti-tumor agents directed against CIB1, a protein implicated in cancer progression that had previously eluded traditional drug discovery methods. This work, which has already garnered 11 citations, exemplifies his commitment to bridging the gap between biological insight and therapeutic application. By enabling rapid, fragment-based hit identification, Hardy’s research is poised to transform how researchers approach the development of chemical tools for the most intractable disease targets, offering a scalable solution to one of modern drug discovery's greatest bottlenecks.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
In silico fragment-based discovery of CIB1-directed anti-tumor agents by FRASE-bot
11 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: University of North Carolina at Chapel Hill

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago